CLA-2 CO:R:C:F 952179 EAB
Martha A. Pierce, Import Specialist
Monsanto Agricultural Company
800 N. Lindbergh Boulevard
St. Louis, Missouri 63167
Re: Sometribove-zinc complex bovine somatotropin (BST); Posilac;
bovine growth hormone; hormones; medicaments; 2937
Dear Ms. Pierce:
This is in reply to your letter dated May 21, 1992, in which
you requested a written ruling on the classification of
sometribove-zinc complex bovine somatotropin (BST) under the
Harmonized Tariff Schedule of the United States Annotated
(HTSUSA).
Although technical and scientific literature accompanies
your request, no sample has been submitted to Customs.
FACTS:
Bovine somatotropin is a natural protein hormone produced in
the pituitary glands of all cattle. When added to cattle feed,
it promotes growth in young calves and milk production in mature
cows.
Monsanto's sometribove-zinc complex BST ("Posilac") is a
recombinant analogue of the naturally occurring hormone that is
formulated with a sesame oil/aluminum monostearate excipient.
The product will be provided commercially in single-dose plastic
syringes that will be packaged 25 to a box containing needles and
instructions for use by dairymen to augment the milk production
of lactating cows.
The substance is manufactured in Austria. Following
solution preparation are the fermentation, isolation, purifica-
tion and freeze-drying steps in the production run, in the final
step of which the bulk powder is mixed with sterilized excipient
to yield the sterile, bulk formulated sometribove-zinc complex.
The sterile formulation is then aseptically filled into unit-
dose syringes which are then labelled and packaged for final use.
Measuring and packaging may occur in Austria or Netherlands.
ISSUE:
What is the classification of sometribove-zinc complex
bovine somatotropin formulated with an excipient and put up in
measured doses to augment milk production in lactating cows?
LAW AND ANALYSIS:
Merchandise imported into the U.S. is classified under the
HTSUSA. The tariff classification of merchandise under the
HTSUSA is governed by the principles set forth in the General
Rules of Interpretation (GRIs) and, in the absence of special
language or context which otherwise requires, by the Additional
U.S. Rules of Interpretation.
GRI 1 requires that classification be determined first
according to the terms of the headings of the tariff schedule and
any relative section or chapter notes and, unless otherwise
required, according to the remaining GRI's taken in order.
Note 2, Section VI, HTSUSA, provides in part that goods
classifiable in heading 3004 by reason of being put up in
measured doses or for retail sale are to be classified in that
heading and in no other heading of the tariff schedule. Since
the product is a hormone that has been so put up, we are of the
opinion that it is not classifiable under heading 2937, but under
heading 3004.
HOLDING:
Sometribove-zinc complex bovine somatotropin formulated with
an excipient and put up in measured doses to augment milk
production in lactating cows is classifiable under subheading
3004.39.0010, HTSUSA, a provision for medicaments (excluding
goods of heading 3002, 3005 or 3006) consisting of mixed or
unmixed products for therapeutic or prophylactic uses; put up in
measured doses or in forms or packings for retail sale;
containing hormones or other products of heading 2937 but not
containing antibiotics; other; for veterinary use.
Entries of merchandise classified under this subheading are
dutiable at the column one general rate of 3.9 percent ad
valorem.
Sincerely,
John Durant, Director
Commercial Rulings Division